<img src="https://ml.globenewswire.com/Resource/Download/85c275df-e665-426f-a3bc-4a839a0b34d3?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Lexeo_Logo.png" alt="Lexeo Therapeutics"/>NEW YORK, Sept. 02, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- <a href="https://www.globenewswire.com/Tracker?data=SbjzxOBEg4Mt1dgCSP-u8ZXP5bYSiaE0bRoMXGxGWSMEiAGL0Xnu-ryVfb1f0NCRc9TafWoJAO6tmcOAe3fwLVH5OzeUM7nv8zFO4fh_Xn8=" rel="nofollow" target="_blank" title="Lexeo Therapeutics, Inc.">Lexeo Therapeutics, Inc.</a> (Nasdaq: LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in September: Cantor Global Healthcare Conference 2026. Fireside chat on Wednesday, September 9, 2026 at 2:10 p.m. ET in New York, NY. Baird 2026 Global Healthcare Conference. Fireside chat on Tuesday, September 15, 2026 at 11:25 a.m. ET in New York, NY. The events will be webcast live under the <a href="https://www.globenewswire.com/Tracker?data=UYcuTQuCn8MjKfn1n9fL899Bon9amayrBF8zFxPH-ci-7l53XYCUSZAIKn3U0SnhNR2plUqoLqb_p_aeHec42mmcADawpbqrOVl7d-pp0QULp-QlSBnQIgbPX9Zm-dTifllvkNetsd7s_IUoRrwXWQ==" rel="nofollow" target="_blank" title="Events &amp; Presentations">Events &amp; Presentations</a> tab in the Investors section of the Company’s website. A replay of the webcasts will be available on the Lexeo website following the presentations. About Lexeo Therapeutics Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The Company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 in Friedreich ataxia (FA), LX2020 in plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need. Media Response: <a href="https://www.globenewswire.com/Tracker?data=THvQyVhflV7ov8RVRubEgGdBi3gLxTISg9hnv9AY1nUGybx_FkRn-oQlsG8uREleE0OlgvKeVEgBNzth9dkWKisEkeIoe4mrPjVM68bWwSk=" rel="nofollow" target="_blank" title="Media@lexeotx.com">Media@lexeotx.com</a> Investor Response: Ashley Kaplowitz <a href="https://www.globenewswire.com/Tracker?data=GAdEW5l4rmYdZIV2Zj24Ak61y3Xp_gQK99otSqXgrDRzoUvoEgCP83Hi9Kh6_DUSDQffMOrHFNuVSuhzMyJm3uY3hfuYv0wZhk4bZBgGI8s=" rel="nofollow" target="_blank" title="akaplowitz@lexeotx.com">akaplowitz@lexeotx.com</a> <img alt="" src='https://ml.globenewswire.com/media/MzgxYTUwNDItMmU5Yi00OTQ4LWJhNzMtNmNhMTk4MGU5Njk2LTEyNDQ3MzktMjAyNi0wOS0wMi1lbg==/tiny/Lexeo-Therapeutics.png' referrerpolicy='no-referrer-when-downgrade' />

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn